These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Murine lupus nephritis. Effects of glucocorticoid on circulating and tissue-bound immunoreactants. Cavallo T, Graves K, Granholm NA. Lab Invest; 1983 Oct; 49(4):476-81. PubMed ID: 6604840 [Abstract] [Full Text] [Related]
11. Lupus nephritis: natural history and therapy. Hecht B, Siegel NJ, Kashgarian M, Hayslett JP. Perspect Nephrol Hypertens; 1976 Oct; 3():21-41. PubMed ID: 175347 [No Abstract] [Full Text] [Related]
12. [Serial studies of serum immune complexes and complements in patients with glomerulonephritis]. Nakayama S, Koide H, Ohno J. Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):163-9. PubMed ID: 6611432 [No Abstract] [Full Text] [Related]
13. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease. Greisman SG, Redecha PB, Kimberly RP, Christian CL. J Immunol; 1987 Feb 01; 138(3):739-45. PubMed ID: 3492531 [Abstract] [Full Text] [Related]
14. Fibronectin binds to C1q: possible mechanisms for their co-precipitation in cryoglobulins from patients with systemic lupus erythematosus. Kono I, Sakurai T, Kabashima T, Yamane K, Kashiwagi H. Clin Exp Immunol; 1983 May 01; 52(2):305-10. PubMed ID: 6602675 [Abstract] [Full Text] [Related]
15. [Correlations between complement degradation products and circulating immune complexes in human glomerulonephritis]. Coppo R, De Marchi M, Alloatti S, Segoloni G, Giacchino F, Quarello F, Roccatello D, Bulzomi MR, Piccoli G. Minerva Nefrol; 1979 May 01; 26(3):243-50. PubMed ID: 318057 [No Abstract] [Full Text] [Related]
16. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus. Sakurai T, Fujita T, Kono I, Kabashima T, Yamane K, Tamura N, Kashiwagi H. Clin Exp Immunol; 1982 Apr 01; 48(1):37-42. PubMed ID: 6979449 [Abstract] [Full Text] [Related]
17. [Use of the C1q binding assay in the analysis of immune complexes: personal experiences with its clinical use and future prospectives]. Corvetta A, Spaeth PJ, Panico F, Ghirelli PA, Orecchioni F, Danieli G. G Clin Med; 1983 Apr 01; 64(9-10):337-48. PubMed ID: 6198235 [No Abstract] [Full Text] [Related]
18. [New facts and trends on research on the pathogenesis of immune glomerulonephritis]. Belobezhdov N. Vutr Boles; 1982 Apr 01; 21(3):1-8. PubMed ID: 6214082 [No Abstract] [Full Text] [Related]
19. [IgG-bound DNA and C1q-binding materials in iupus nephritis]. Koyama A, Narita M, Lshida H, Inage H, Sano M, Tojo S. Nihon Jinzo Gakkai Shi; 1982 Mar 01; 24(3):267-74. PubMed ID: 6981719 [No Abstract] [Full Text] [Related]